Knockdown of Serine Threonine Tyrosine Kinase 1 (STYK1) Inhibits the Migration and Tumorigenesis in Glioma Cells-Reference-Cited by-同舟云学术

Knockdown of Serine Threonine Tyrosine Kinase 1 (STYK1) Inhibits the Migration and Tumorigenesis in Glioma Cells

Published:2017-07-05 Issue:6 Volume:25 Page:931-937
ISSN:0965-0407
Container-title:Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
language:en
Short-container-title:oncol res

Author:

Zhou Jianping¹,Wang Fan²,Liu Bingli³,Yang Lin¹,Wang Xueying¹,Liu Yu¹

Affiliation:

1. Department of Pediatrics, The Second Affiliated Hospital, Medical College of Xi’an Jiaotong University, Xi’an, P.R. China

2. Department of Obstetrics and Gynecology, Shaanxi Provincial People’s Hospital, Xi’an, P.R. China

3. Department of General Surgery, The Second Affiliated Hospital, Medical College of Xi’an Jiaotong University, Xi’an, P.R. China

Abstract

Pediatric glioma is a devastating brain tumor. Serine threonine tyrosine kinase 1 (STYK1) is a member of the protein tyrosine kinase family and plays a significant role in the formation of several malignant tumors. However, the expression pattern and role of STYK1 in glioma are not yet clear. The aim of this study was to investigate the role and molecular mechanism of STYK1 in glioma. The results showed that STYK1 was highly expressed in glioma cell lines. We also found that knockdown of STYK1 inhibited cell proliferation, migration, and invasion in vitro as well as tumorigenesis in vivo. Furthermore, knockdown of STYK1 significantly decreased the expression levels of phosphorylation of PI3K and Akt in glioma cells. Taken together, our data suggest that STYK1 plays an important role in the development and progression of glioma. Therefore, STYK1 may represent a novel therapeutic target for the treatment of glioma.

Publisher

Cognizant, LLC

Subject

Cancer Research,Oncology,General Medicine

Reference25 articles.

1. Outcome and prognostic features in pediatric gliomas: A review of 6212 cases from the Surveillance, Epidemilology, and End Results Database;Cancer,2009

2. EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines;Clin Cancer Res.,2009

3. Nimotuzumab in pediatric glioma;Future Oncol.,2016

4. Prognostic and predictive biomarkers in adult and pediatric gliomas: Toward personalized treatment;Front Oncol.,2014

5. Isolation and characterization of a human putative receptor protein kinase cDNA STYK1;Mol Biol Rep.,2003

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NOK promotes tumorigenesis through coordinating epidermal growth factor receptor to boost the downstream signaling in breast cancer;2024-08-15

2. Cryptic sequence features in the active postmortem transcriptome;BMC Genomics;2018-09-14

3. Distinct sequence patterns in the active postmortem transcriptome;2018-04-02

4. Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients;Oncotarget;2017-11-30